2 abril 2015
Spreading the success of cancer immunotherapy beyond those patients currently enjoying powerful, long-term responses to treatment requires greater understanding of the immune response to tumors, two leaders in the field note in a new review.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/upF2_K-egzo/150402161503.htm
